BEIJING, April 3, 2026 /PRNewswire/ -- Syneron Bio, a leader in intelligent platform-driven macrocyclic peptide drug discovery, announced the successful closing of its Series B financing on March 31th. The round was led by an international life-science fund, with co-lead participation...
Hence then, the article about syneron bio announces completion of 150 million series b financing was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Syneron Bio Announces Completion of $150 Million Series B Financing )
Also on site :
- Get Your First Look at a New Dark Academia Fantasy ‘Our Dark Incantations’ by Wanda Hellmund [Exclusive]
- As U.S. Treasury intervened in the bond market, the Netherlands rushed 86 tons of gold out of America because of ‘geopolitical unrest’
- Little-Known 2014 Eric Dane Series, Based on a 1988 Novel, Has Quietly Become One of 2026’s Most-Streamed Shows